The Basel-based pharma company BioVersys has received 2.7 million euros in funding alongside two partners.…
annett03.01.2021
A group of experienced Swiss entrepreneurs and private investors have participated in a significantly oversubscribed…
martin02.11.2021
The United States Food and Drug Administration has granted accelerated approval for the drug Umbralisib.…
martin02.10.2021
Basel biotech Novaremed is receiving US$50 million through an agreement with an investment group. Novaremed…
martin02.03.2021
The US firm Axtria has established a new office in Basel. The company offers services…
martin02.01.2021
The canton of Basel-Stadt has displayed the most striking performance in the Swiss Venture Capital…
martin01.28.2021
Researchers from Basel are working on the development of a therapy in which pre-prepared immune…
martin01.26.2021
Opterion is moving from the canton of Obwalden to Muttenz in the canton of Basel-Landschaft…
martin01.22.2021
